mProX™ Human EPHA1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Linda
Verified Customer
Karen
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Expression of EphA1 in colon cancer cell lines.
The expression of the EphA1 transcript in the colon cancer cell lines DLD1, HT29, HCT116, SW480, and SW620 was determined by RT-PCR. All of the colon cancer cell lines had EphA1 mRNA.
Ref: Dong, Yingchun, et al. "Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis." Modern Pathology 22.1 (2009): 151-160.
Pubmed: 19011600
DOI: 10.1038/modpathol.2008.188
Research Highlights
The findings indicate that the rs11767557 mutation may be able to substantially control the expression of the EPHA1 gene in human whole blood. These results may also offer significant additional information regarding the rs11767557 variant's regulatory mechanisms in relation to AD risk.
Liu, Guiyou, et al. "Alzheimer's disease rs11767557 variant regulates EPHA1 gene expression specifically in human whole blood." Journal of Alzheimer's Disease 61.3 (2018): 1077-1088.
Pubmed:
29332039
DOI:
10.3233/JAD-170468
RTK EphA1 is a valuable therapeutic target for novel anti-tumor therapeutics, a biomarker for tumor diagnosis (particularly as a prognostic sign), and a new anti-tumor medication.
Wu, Yinxin, et al. "The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors." Current Medicinal Chemistry 30.20 (2023): 2340-2353.
Pubmed:
35996244
DOI:
10.2174/0929867329666220820125638